has been cited by the following article(s):
|
[1]
|
Chemotherapy and Colorectal Cancer
|
|
… Cancer Diagnosis and …,
2022 |
|
|
|
|
[2]
|
Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI±Bevacizumab: A Western Canadian …
|
|
2021 |
|
|
|
|
[3]
|
Colorectal cancer screening and awareness among patients attending outpatient clinic at Muhimbili National Hospital (MNH), Dar Es Salaam-Tanzania
|
|
2018 |
|
|
|
|
[4]
|
Design, Synthesis and Pharmacological Screening of Novel 1, 3, 4-Thiadiazole derivatives
|
|
2017 |
|
|
|
|
[5]
|
Design Synthesis and Pharmacological Screening of Novel 1 3 4 Thiadiazole derivatives
|
|
2017 |
|
|
|
|
[6]
|
The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment
|
|
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,
2017 |
|
|
|
|
[7]
|
Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer
|
|
Annals of Surgical Oncology,
2016 |
|
|
|
|
[8]
|
Management of the Primary Tumor in Metastatic Colorectal Cancer
|
|
2016 |
|
|
|
|
[9]
|
The Management of the Primary Tumor in Patients with Metastatic Colorectal Cancer
|
|
Colorectal Cancer From Pathogenesis To Treatment,
2016 |
|
|
|
|
[10]
|
Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy
|
|
Oncology,
2015 |
|
|
|
|
[11]
|
Predictive factors of the use of systemic therapy in stage IV colorectal cancer: who gets chemotherapy?
|
|
Oncology,
2015 |
|
|
|
|
[12]
|
Advances in the management of colorectal cancer: from biology to treatment
|
|
International journal of colorectal …,
2014 |
|
|
|
|
[1]
|
Rate of Curative Surgery in Real-world Patients with Unresectable Metastatic Colorectal Cancer Treated with FOLFOXIRI ± Bevacizumab: A Western Canadian Province Experience
Journal of Gastrointestinal Cancer,
2022
DOI:10.1007/s12029-021-00634-w
|
|
|
|
|
[2]
|
The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research,
2017
DOI:10.1016/j.bbamcr.2017.09.004
|
|
|
|
|
[3]
|
Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer
Annals of Surgical Oncology,
2016
DOI:10.1245/s10434-016-5200-9
|
|
|
|
|
[4]
|
Predictive Factors of the Use of Systemic Therapy in Stage IV Colorectal Cancer: Who Gets Chemotherapy?
Oncology,
2015
DOI:10.1159/000368245
|
|
|
|
|
[5]
|
Advances in the management of colorectal cancer: from biology to treatment
International Journal of Colorectal Disease,
2014
DOI:10.1007/s00384-014-1928-5
|
|
|
|